The chief scientist of the company is an internationally renowned scholar with a strong background in the field of gene editing and stem cell therapy,. His key findings have been published in top-notch journals, including Cell, Blood, Leukemia, Stem Cell Reports, Cell Research, Stem Cell Translational Medicine. The R & D team consists of a group of domestic and foreign postdoctoral fellows, professors and experts in the field; 80% of its R & D team members have master's degree or above, and the backbone of young and middle-aged scientists further enhance the team's creativity.